Evaluation of Monoclonal Antibodies to vWf Antigen for Use in Autoradiographing vWf Multimer Analysis

Summary

Nine monoclonal antibodies (MAb, coded ESvWF 1-5, 7-10) to human von Willebrand’s factor (vWf) have been studied for their labelling characteristics with ¹²⁵I and their ability to demonstrate vWf multimers by autoradiography after discontinuous SDS electrophoresis on agarose and agarose/acrylamide gels in plasma from normal and von Willebrand’s disease (vWD) patients. Of ESvWF 1, 2, 4, 7, 8 and 9, ESvWF 2 gave autoradiographs most similar to those obtained with a polyclonal antibody. The others gave much fainter staining of all bands suggesting that the epitope detected by ESvWF 2 is either more common or, less easily altered by SDS than the epitopes identified by the other MAb’s. ESvWF 2 gave a different staining pattern with a IIC vWD patient than that obtained using a polyclonal antibody. The most striking result, however, was shown by ESvWF 3, 5 and 10 which failed to stain the lower band of the lower molecular weight multimer. This suggests that the lower triplet band, unlike the central and upper bands of the triplet, does not contain the epitope identified by these three MAb’s. With these reagents it has been possible to show, for the first time, that epitope differences do exist between the constituent bands of the vWf triplet.

Keywords

Monoclonal antibodies - vWf antigen - Autoradiography - Multimeric analysis

• References

• 1 Hoyer LW. The Factor VIII complex: Structure and function. Blood 1981; 58: 1-13
• 2 Zimmerman TS, Ruggeri ZM, Fulcher CA. Factor VIII-von Willebrand factor. In Progress in haematology. Spaet TH. (Ed.) Grune and Stratton Inc; New York: 1983. 13 279-309
• 3 Kernoff P BA, Gruson R, Rizza CR. A variant of Factor VIII related antigen. Br J Haematol 1974; 26: 435-440
• 4 Peake IR, Bloom AL, Giddings JC. Inherited variants of factor VIII-related protein in von Willebrand’s disease. N Engl J Med 1974; 291: 113-117
• 5 Hill F GH, Chan M CK, Hardisty RM. Von Willebrand’s syndrome studies on a variant factor VIII. Haemostasis 1976; 5: 276-284
• 6 Gralnick HR, Sultan Y, Coller BS. Von Willebrand’s disease combined qualitative and quantitative abnormalities. N Engl J Med 1977; 296: 1024-1030
• 7 Ruggeri ZM, Zimmerman TS. Variant von Willebrand’s disease: Characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelet. J Clin Invest 1980; 65: 1318-1325
• 8 Ruggeri ZM, Zimmerman TS. The complex multimeric composition of Factor VIII/von Willebrand factor. Blood 1981; 57: 1140-1143
• 9 Enayat MS, Hill F GH. Analysis of the complexity of the multimeric structure of F VIII related antigen/von Willebrand protein using a modified electrophoretic technique. J Clin Path 1983; 36: 915-919
• 10 Ruggeri ZM, Nilsson IM, Lombardi R, Holmberg L, Zimmerman TS. Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand’s disease (Type IIC). J Clin Invest 1982; 70: 1124-1127
• 11 Kinoshita S, Harrison J, Lazerson J, Abildgaard CF. A new variant of dominant type II von Willebrand’s disease with aberrant multimeric pattern of Factor VIII-Related antigen. (Type IID). Blood 1984; 63: 1369-1371
• 12 Hoyer LW, Rizza CR, Tuddenham E GD, Carta CA, Armitage H, Rotblat F. von Willebrand factor multimer patterns in von Wllebrand’s disease. Br J Haematol 1983; 55: 493-507
• 13 Ciavarella G, Ciavarella N, Antoncecchi S, De Mattia D, Ranieri P, Dent J, Zimmerman TT, Ruggeri ZM. High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC). Blood 1985; 66: 1423-1429
• 14 Katzmann JA, Mujwid DK, Miller RS, Fass DN. Monoclonal antibodies to von Wllebrand’s factor: Reactivity with porcine and human antigens. Blood 1981; 58: 530-536
• 15 Sola B, Avner P, Sultan Y, Jeanneau C, Maisoneuve P. Monoclonal antibodies against human factor VIII molecule neutralise antihemophilic factor and ristocetin cofactor activities. Proc Natl Acad Sci USA 1982; 79: 183-187
• 16 Bowie E JW, Fass DN, Katzmann JA. Functional studies of von Willebrand factor using monoclonal antibodies. Blood 1983; 62: 146-151
• 17 Kirby EP, Edgington TS. Characterization of monoclonal antibodies to bovine von Willebrand factor. Thromb Haemostas 1983; 50: 191 (Abstr.)
• 18 Goodall AH, Jarvis J, Chand S, Rawlings E, O’Brien DD, McCraw A, Hutton R, Tuddenham E GD. An immunoradiometric assay for human factor VIII-von Willebrand factor using monoclonal antibodies that define a functional epitope. Br J Haematol 1985; 59: 565-577
• 19 Bradley LA, Franco EL, Reisner HM. Use of monoclonal antibodies in an enzyme immunoassay for Factor VIII-Related antigen. Clin Chem 1984; 30: 87-92
• 20 Meyer D, Zimmerman TS, Obert B, Edgington TS. Hybridoma antibodies to human von Willebrand factor. I. Characterization of seven clones. Br J Haematol 1984; 57: 597-608
• 21 Stel HV, Sakariassen KS, Scholte BJ, Veerman E CI, van der Kwast ThH, de Groot PhG, Sixma JJ, van Mourik JA. Characterisation of 25 monoclonal antibodies to Factor VIII-von Willebrand factor: Relationship between ristocetininduced platelet aggregation and platelet adherence to subendothelium. Blood 1984; 63: 1408-1415
• 22 Schullek J, Jordan T, Montgomery R. Interaction of von Willebrand factor with human platelets in the plasma milieu. J Clin Invest 1984; 73: 421-428
• 23 Ogata K, Saito H, Ratnoff OD. The relationship of the properties of antihemophilic Factor (Factor VIII) that supports ristocetin-induced platelet agglutination (Factor VIII R:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody. Blood 1983; 61: 27-35
• 24 Nokes T JC, Mahmoud NA, Savidge GF, Goodall AH, Meyer D, Edgington TS, Hardisty RM. Von Willebrand factor has more than one binding site for platelets. Thromb Res 1984; 34: 361-366
• 25 Meyer D, Baumgartner HR, Edgington TS. Hybridoma antibodies to human von Willebrand factor. II Relative role of intramolecular loci in mediation of platelet adhesion to the subendothelium. Br J Haematol 1984; 57: 609-620
• 26 Goodall AH, Meyer D. Registry of monoclonal antibodies to factor VIII and von Willebrand’s factor. Thromb Haemostas 1985; 54: 878-891
• 27 Lamme S, Wallmark A, Holmberg L, Nilsson IM, Sjogren HO. The use of monoclonal antibodies in measuring Factor VIII/von Willebrand factor. Scand J Clin Lab Invest 1985; 45: 17-26
• 28 Mannucci PM, Abildgaard CF, Gralnick HR, Hill F GH, Hoyer LW, Lombardi R, Nilsson IM, Tuddenham E, Meyer D. Multicentre comparison of von Willebrand factor multimer sizing techniques. Report of the factor VIII and von Willebrand factor subcommitte. Thromb Haemostas 1985; 54: 873-877
• 29 Hornsey V, Micklem LR, McCann MC, James K, Dawes J, McClelland D BL, Prowse CV. Enhancement of Factor VIII-von Willebrand factor ristocetin cofactor activity by monoclonal antibodies. Thromb Haemostas 1985; 54: 510-514
• 30 Hill F GH, Enayat MS, George AJ. Investigation of a kindred with a new autosomal dominantly inherited variant type von Willebrand’s disease (possible type IID). J Clin Pathol 1985; 38: 665-670
• 31 Davies AG, Lawrence NR, Lynch SS. Binding of ¹²⁵I-labelled FSH in the mouse testis in vivo. J Reprod Fert 1978; 53: 249-254
• 32 Butt WR. The iodination of follicle stimulating and other hormones for radioimmunoassay. J Endocrinol 1972; 55: 453-454
• 33 Enayat MS, Hill F GH. Qualitative VIIIR:Ag function screening of multiple samples by two dimensional crossed immunoelectrophoresis technique. Med Lab Sci 1982; 39: 357-362